The patient’s EGFR CA repeat genotype was found not to be associated with tumor stage, tumor differentiation, lymph node metastasis or tumor aggressiveness factors, including skin, bone and perineural invasion (Table 3). The gene discussed is EGFR; the disease is metastatic malignant neoplasm in the lymph nodes.